The Effect of Combined Upper and Lower Extremity Endurance Training in Patients With ICD (ICD)
Heart Failure With Reduced Ejection Fraction
About this trial
This is an interventional treatment trial for Heart Failure With Reduced Ejection Fraction focused on measuring Implantable cardiac defibrillator, Upper extremity endurance training, peak Oxygen consumption, upper extremity functional capacity
Eligibility Criteria
Inclusion Criteria:
- Patients with a diagnosis of heart failure in the New York Heart Association (NYHA) class II-III, who have had at least 3 months past ICD implantation, and who did not have any complications at the last pacemaker control,
- Ejection fraction (EF) value ≤45%,
- The medicines used have not been changed for at least 3 months,
- Volunteering to participate in the research, being able to attend a 1-hour rehabilitation program every day of the week,
- To be clinically stable, to be under control if any accompanying comorbid conditions (such as hypertension, diabetes),
- Not having any orthopedic problems that may prevent him from exercising with his bicycle and arm ergometer,
- CPET, ambulatory blood pressure and rhythm monitoring, ECG and ECHO without any obstacle to exercise within the framework of TKD cardiology guidelines (such as moderate valve disease, hypertrophic cardiomyopathy, severe uncontrolled HT…).
Exclusion Criteria:
- Those with a history of shoulder injury (severe pain around the shoulder and inability to move, severe swelling around the shoulder, shoulder dislocation)
- Those with a history of shoulder surgery,
- Sequelae of a cerebrovascular accident with mastectomy or arm involvement on the affected side,
- Having decompensated heart failure,
- Having an obstacle to exercise within the framework of TSC (Turkish Society of Cardiology) cardiology guidelines in CPET, ambulatory blood pressure and rhythm monitoring, ECG and ECO (such as moderate valve disease, hypertrophic cardiomyopathy, severe uncontrolled HT ...)
- Having a history of ICD shock in the last 6 months,
- Having an active treated malignancy or a collagen tissue disease receiving systemic steroids
- Being unable to cooperate or adapt to exercise due to cerebrovascular disease or other reasons,
- Having a chronic kidney disease undergoing dialysis where the volume load is not stable.
Sites / Locations
- Hitit UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
control group
intervention group
After the evaluations are completed, the participants will be randomly divided into two groups using a computer-assisted randomization program. The cardiac rehabilitation program will be a total of 30 sessions, 5 days a week x 6 weeks. All patients in the control and study groups will participate in the routine lower extremity bicycle ergometer training
The combined upper and lower extremity training group will participate in the arm ergometer exercise separately from the lower extremity training group.